NJ Panel Upholds Elan's $3.4M Tax Bill On Drug Asset Sale
By Daniel Tay · January 26, 2021, 2:56 PM EST
The New Jersey Tax Court properly upheld pharmaceutical giant Elan's $3.4 million tax liability from selling drug assets, a state appeals court said Tuesday, rejecting the company's assertion that the gain...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login